No connection

Search Results

AXON

NEUTRAL
$613.14 Live
Axon Enterprise, Inc. · NASDAQ
Target $815.0 (+32.9%)
$469.24 52W Range $885.92

At a glance

Key valuation, profitability, growth, and risk metrics.

Updated Jan 24, 2026
Market cap
$48.71B
P/E
192.21
ROE
10.0%
Profit margin
10.1%
Debt/Equity
0.69
Dividend yield
N/A

AI Analysis

AI-powered fundamental assessment

Confidence
68%
AXON's Advanced Deterministic Scorecard shows a Piotroski F-Score of 6/9, indicating stable financial health, but the absence of an Altman Z-Score limits distress risk assessment. The stock trades at a significant premium to both the Graham Number ($52.48) and intrinsic value ($22.33), supported by strong revenue growth (30.6% YoY) and consistent earnings beats, though recent negative EPS growth and insider selling raise concerns. Profitability is mixed with a healthy gross margin (60.36%) but negative operating and asset returns (ROA: -0.03%, Operating Margin: -0.23%). Analysts maintain a 'buy' recommendation with a $815 target, implying 33% upside, but insider sentiment is bearish, and technical trend is neutral to weak.

Key Strengths

Strong revenue growth of 30.6% YoY, well above sector average of 18.6%
Consistent earnings beat streak with 3 out of last 4 quarters exceeding estimates and an average surprise of 22.87%
High gross margin of 60.36%, reflecting pricing power and efficient cost control in core operations
Solid liquidity position with a current ratio of 3.12 and quick ratio of 2.73, indicating strong short-term financial health
Analyst consensus remains bullish with a $815 target price, suggesting substantial upside potential

Key Risks

Extremely high valuation metrics: P/E of 192.21 and Forward P/E of 81.34, far exceeding sector average of 54.20
Negative operating margin (-0.23%) and ROA (-0.03%) indicate core operations are not currently profitable on an operating basis
Recent YoY and Q/Q EPS growth are deeply negative (-102.1% and -101.4% respectively), signaling a sharp earnings downturn
Insider activity is strongly bearish with $34.68M in net selling over the past 6 months, including multiple executive sales
Missing key financial data (Altman Z-Score, ROIC, cash/debt figures) creates uncertainty in financial health and leverage assessment
AI Fair Value Estimate
Based on comprehensive analysis
$52.48
-91.4% below current price

Performance Snowflake

Multi-dimensional analysis across 5 key categories

Overall
49
Moderate
Value
30
Future
75
Past
70
Health
60
Dividend
10
AI Verdict
Neutral with upside risk if growth materializes
Key drivers: High revenue growth and earnings beat consistency, Elevated valuation and negative earnings momentum, Strong liquidity but weak operating profitability, Bullish analyst outlook vs bearish insider behavior, Missing Altman Z-Score and cash flow data limit health assessment
Confidence
70%
Value
30/100

Ref P/E, PEG, Graham Number

Positives
  • Analyst target implies strong future value realization
Watchpoints
  • Current price ($613.14) is 10.7x the Graham Number ($52.48)
  • P/E of 192.21 and Price/Book of 15.98 are extremely high
  • Intrinsic value estimate of $22.33 suggests deep overvaluation
Future
75/100

Ref Growth rates

Positives
  • 30.6% YoY revenue growth is robust and accelerating
  • Analyst target suggests strong future earnings expectations
  • Historical earnings surprise trend indicates execution capability
Watchpoints
  • Negative YoY and Q/Q EPS growth (-102.1%, -101.4%)
  • Forward P/E still high at 81.34 despite earnings decline
Past
70/100

Ref Historical trends

Positives
  • Long streak of earnings beats (22 of last 25 quarters)
  • Average earnings surprise of 22.87% over last 4 quarters
  • 5Y price return of +251.3% shows strong historical performance
Watchpoints
  • 1Y price return flat at 0.0%, underperforming growth narrative
  • 6M return of -16.6% indicates recent weakness
Health
60/100

Ref Altman Z-Score, Piotroski F-Score

Positives
  • Piotroski F-Score of 6/9 indicates stable financial health
  • Current ratio (3.12) and quick ratio (2.73) show strong liquidity
Watchpoints
  • Altman Z-Score not available, limiting distress risk analysis
  • ROA is negative (-0.03%) and operating margin is negative (-0.23%)
  • Debt/Equity of 0.69 is moderate but lacks context without cash/debt figures
Dividend
10/100

Ref Yield, Payout

Positives
No standout positives identified.
Watchpoints
  • No dividend yield or payout history
  • Dividend Strength score of 0/100
  • No indication of capital return policy

Stock Price & Analyst Targets

Real-time price movements and analyst price targets

Current Price
$613.14
Analyst Target
$815.0
Upside/Downside
+32.9%

Multi-Horizon Performance vs Peers

Price momentum across 5Y → 1W horizons for AXON and closest competitors.

Updated 2026-01-23
AXO
Axon Enterprise, Inc.
Primary
5Y
+251.3%
3Y
+224.5%
1Y
-0.0%
6M
-16.6%
1M
+3.7%
1W
-3.6%
RKL
Rocket Lab Corporation
Peer
5Y
+689.6%
3Y
+1978.4%
1Y
+329.6%
6M
+28.0%
1M
+22.1%
1W
+24.6%
FAS
Fastenal Company
Peer
5Y
+89.3%
3Y
+68.9%
1Y
+0.6%
6M
-1.6%
1M
-3.7%
1W
-1.0%
CAR
Carrier Global Corporation
Peer
5Y
+43.0%
3Y
+27.2%
1Y
-26.9%
6M
-28.0%
1M
-5.1%
1W
-5.9%
AME
AMETEK, Inc.
Peer
5Y
+96.0%
3Y
+56.2%
1Y
+16.7%
6M
+23.0%
1M
+6.0%
1W
+2.4%

Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.

Historical Performance Trends

Long-term financial metrics and growth patterns

Revenue & Net Income

Profit & Operating Margins

Return on Equity (ROE)

Quarterly Revenue Growth

Historical data shows last 12 quarters (3 years)

Valuation Metrics

Key valuation ratios and pricing indicators

P/E Ratio
192.21
Forward P/E
81.34
PEG Ratio
N/A
P/B Ratio
15.98
P/S Ratio
19.04
EV/Revenue
18.78
EV/EBITDA
674.69
Market Cap
$48.71B

Profitability

Profit margins and return metrics

Profit Margin 10.05%
Operating Margin -0.23%
Gross Margin 60.36%
ROE 10.03%
ROA -0.03%

Growth

Revenue and earnings growth rates

Revenue Growth +30.6%
Earnings Growth N/A
Q/Q Revenue Growth N/A
Q/Q Earnings Growth N/A

Financial Health

Balance sheet strength and liquidity metrics

Debt/Equity
0.69
Moderate
Current Ratio
3.12
Strong
Quick Ratio
2.73
Excellent
Cash/Share
$30.98

Quarterly Earnings History

EPS performance vs analyst estimates

2026-02-24
$N/A
2025-11-04
$-0.03
+13.3% surprise
2025-08-04
$2.12
+45.0% surprise
2025-05-07
$1.41
+10.2% surprise

Industrials Sector Comparison

Comparing AXON against 469 companies in the Industrials sector (39 bullish, 174 neutral, 256 bearish)
P/E Ratio
192.21
This Stock
vs
98.24
Sector Avg
+95.7% (Expensive)
Return on Equity (ROE)
10.03%
This Stock
vs
-19.38%
Sector Avg
-151.7% (Below Avg)
Profit Margin
10.05%
This Stock
vs
6.65%
Sector Avg
+51.1% (Superior)
Debt to Equity
0.69
This Stock
vs
2.63
Sector Avg
-73.7% (Less Debt)
Revenue Growth
30.6%
This Stock
vs
71.29%
Sector Avg
-57.1% (Slower)
Current Ratio
3.12
This Stock
vs
3.09
Sector Avg
+1.1% (Better)

Similar Companies

Peer comparison within the same industry

Recent Insider Trading

Insider buy and sell transactions from the last 6 months

SMITH PATRICK W.
Chief Executive Officer
Sell
2026-01-07
10,000 shares · $6,190,146
MAK JENNIFER H
Officer
Sell
2025-12-19
1,134 shares · $680,400
KALINOWSKI CAITLIN ELIZABETH
Director
Gift
2025-12-15
180 shares
MAK JENNIFER H
Officer
Stock Award
2025-12-15
1,359 shares
BAGLEY BRITTANY
Chief Operating Officer
Sell
2025-12-11
2,000 shares · $1,160,000
SMITH PATRICK W.
Chief Executive Officer
Sell
2025-12-08
10,000 shares · $5,519,164
ISNER JOSHUA M
President
Sell
2025-12-08
20,000 shares · $11,052,007
WILLIAMS JERI L
Director
Sell
2025-12-04
100 shares · $55,063
MAK JENNIFER H
Officer
Sell
2025-12-04
894 shares · $491,700
ISNER JOSHUA M
President
Sell
2025-12-03
2,041 shares · $1,092,150
MAK JENNIFER H
Officer
Sell
2025-12-03
74 shares · $39,720
KUNINS JEFFREY C
Chief Technology Officer
Sell
2025-12-02
1,797 shares · $968,992
BROOKS CAMERON DAVID
Officer
Stock Award
2025-11-13
15,810 shares
SMITH PATRICK W.
Chief Executive Officer
Stock Award
2025-11-13
97,015 shares
BAGLEY BRITTANY
Chief Operating Officer
Stock Award
2025-11-13
30,560 shares
Insider transactions can signal confidence or concerns about company prospects

Wall Street Analysts

Professional analyst ratings and price targets

Consensus
BUY
17 analysts
Morgan Stanley
2025-12-17
Maintains
Overweight Overweight
RBC Capital
2025-11-17
init
Outperform
Barclays
2025-11-06
Maintains
Overweight Overweight
UBS
2025-11-05
Maintains
Neutral Neutral
Goldman Sachs
2025-11-05
Maintains
Buy Buy
Piper Sandler
2025-11-05
Maintains
Overweight Overweight
JMP Securities
2025-09-29
reit
Market Outperform Market Outperform
Piper Sandler
2025-09-24
init
Overweight
Needham
2025-09-24
reit
Buy Buy
B of A Securities
2025-08-06
Maintains
Buy Buy

Past News Coverage

Recent headlines mentioning AXON from our newsroom.

Newest → oldest
TradingGPT V2 Copilot
Fundamentals • Valuation • Risk
Hi! I'm your fundamentals copilot.

Ask me to:
• Summarize the business quality
• Review valuation and multiples
• Highlight risks and red flags
• Explain growth and margin trends
Home
Terminal
AI Chat
Markets
Profile